Danielle Verver

9PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersInnate immunityMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Physiotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 28, 2021
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.

Danielle Verver, Dirk J Grünhagen, Alexander C J van Akkooi

|Oct 25, 2019
Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.

Daniëlle Verver, Vichnou Poirier-Colame, Gorana Tomasic

|Aug 20, 2019
Author's reply to: The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous.

Danielle Verver, Astrid A M van der Veldt, Alexander C J van Akkooi

|Feb 26, 2019
Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population-based study.

D Verver, Aam van der Veldt, Acj van Akkooi

Pageof 2